3-carbethoxypsoralen has been researched along with 4,4',6-trimethylangelicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, S; Mizuno, N; Takakuwa, Y; Takashima, A; Yamamoto, K | 1 |
| Averbeck, D; Bisagni, E; Chen, X; Dall'Acqua, F; Kagan, J; Miolo, G | 1 |
2 other study(ies) available for 3-carbethoxypsoralen and 4,4',6-trimethylangelicin
| Article | Year |
|---|---|
Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
Topics: Adult; Dermatitis, Contact; Female; Furocoumarins; Humans; Incidence; Male; Methoxsalen; Middle Aged; Photosensitivity Disorders; Psoriasis; PUVA Therapy; Skin Tests | 1991 |
Photosensitized cross-linking and cleavage of pBR322 and M13 DNA: comparison of 4,4',6-trimethylangelicin and 3-carbethoxypsoralen.
Topics: Bacteriophage M13; Deoxyribonucleases, Type II Site-Specific; DNA Damage; DNA, Viral; Furocoumarins; Light; Methoxsalen; Nucleic Acid Denaturation; Photochemotherapy; Plasmids; Radiation-Sensitizing Agents; Restriction Mapping | 1994 |